179 related articles for article (PubMed ID: 38594603)
21. Serial T2-Weighted Magnetic Resonance Images Acquired on a 1.5 Tesla Magnetic Resonance Linear Accelerator Reveal Radiomic Feature Variation in Organs at Risk: An Exploratory Analysis of Novel Metrics of Tissue Response in Prostate Cancer.
Lorenz JW; Schott D; Rein L; Mostafaei F; Noid G; Lawton C; Bedi M; Li XA; Schultz CJ; Paulson E; Hall WA
Cureus; 2019 Apr; 11(4):e4510. PubMed ID: 31259119
[TBL] [Abstract][Full Text] [Related]
22. Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis.
Scott JG; Sedor G; Ellsworth P; Scarborough JA; Ahmed KA; Oliver DE; Eschrich SA; Kattan MW; Torres-Roca JF
Lancet Oncol; 2021 Sep; 22(9):1221-1229. PubMed ID: 34363761
[TBL] [Abstract][Full Text] [Related]
23. Preoperative radiotherapy for adult head and neck soft tissue sarcoma: assessment of wound complication rates and cancer outcome in a prospective series.
O'Sullivan B; Gullane P; Irish J; Neligan P; Gentili F; Mahoney J; Sellmann S; Catton C; Waldron J; Brown D; Witterick I; Freeman J; Bell R
World J Surg; 2003 Jul; 27(7):875-83. PubMed ID: 14509522
[TBL] [Abstract][Full Text] [Related]
24. [Radiation Therapy for Management of Soft Tissue Sarcomas].
Sumi M
Gan To Kagaku Ryoho; 2016 Jan; 43(1):39-43. PubMed ID: 26809526
[TBL] [Abstract][Full Text] [Related]
25. Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03).
Jakob J; Simeonova A; Kasper B; Ronellenfitsch U; Rauch G; Wenz F; Hohenberger P
Radiat Oncol; 2016 Jun; 11():77. PubMed ID: 27255678
[TBL] [Abstract][Full Text] [Related]
26. Update on Dosing and Fractionation for Neoadjuvant Radiotherapy for Localized Soft Tissue Sarcoma.
Roohani S; Wiltink LM; Kaul D; Spałek MJ; Haas RL
Curr Treat Options Oncol; 2024 Apr; 25(4):543-555. PubMed ID: 38478330
[TBL] [Abstract][Full Text] [Related]
27. Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib.
Endo M; Kataoka T; Fujiwara T; Tsukushi S; Takahashi M; Kobayashi E; Yamada Y; Tanaka T; Nezu Y; Hiraga H; Wasa J; Nagano A; Nakano K; Nakayama R; Hamada T; Kawano M; Torigoe T; Sakamoto A; Asanuma K; Morii T; Machida R; Sekino Y; Fukuda H; Oda Y; Ozaki T; Tanaka K
BMC Cancer; 2023 Mar; 23(1):219. PubMed ID: 36890471
[TBL] [Abstract][Full Text] [Related]
28. Outcomes and computed tomography radiomic features extraction in soft tissue sarcomas treated with neoadjuvant radiation therapy.
González-Viguera J; Reynés-Llompart G; Lozano A
Rep Pract Oncol Radiother; 2021; 26(5):804-813. PubMed ID: 34760315
[TBL] [Abstract][Full Text] [Related]
29. Predicting pathological complete response of neoadjuvant radiotherapy and targeted therapy for soft tissue sarcoma by whole-tumor texture analysis of multisequence MRI imaging.
Miao L; Cao Y; Zuo L; Zhang H; Guo C; Yang Z; Shi Z; Jiang J; Wang S; Li Y; Wang Y; Xie L; Li M; Lu N
Eur Radiol; 2023 Jun; 33(6):3984-3994. PubMed ID: 36580095
[TBL] [Abstract][Full Text] [Related]
30. Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancer.
Beer L; Martin-Gonzalez P; Delgado-Ortet M; Reinius M; Rundo L; Woitek R; Ursprung S; Escudero L; Sahin H; Funingana IG; Ang JE; Jimenez-Linan M; Lawton T; Phadke G; Davey S; Nguyen NQ; Markowetz F; Brenton JD; Crispin-Ortuzar M; Addley H; Sala E
Eur Radiol; 2021 Jun; 31(6):3765-3772. PubMed ID: 33315123
[TBL] [Abstract][Full Text] [Related]
31. Current trials and new aspects in soft tissue sarcoma of adults.
Issels RD; Schlemmer M
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
[TBL] [Abstract][Full Text] [Related]
32. Distinct patterns of the natural evolution of soft tissue sarcomas on pre-treatment MRIs captured with delta-radiomics correlate with gene expression profiles.
Crombé A; Bertolo F; Fadli D; Kind M; Le Loarer F; Perret R; Chaire V; Spinnato P; Lucchesi C; Italiano A
Eur Radiol; 2023 Feb; 33(2):1205-1218. PubMed ID: 36029343
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of a multiparametric MRI protocol for imaging biomarkers associated with neoadjuvant radiotherapy for soft tissue sarcoma.
Kershaw L; Forker L; Roberts D; Sanderson B; Shenjere P; Wylie J; Coyle C; Kochhar R; Manoharan P; Choudhury A
BJR Open; 2021; 3(1):20200061. PubMed ID: 35707756
[TBL] [Abstract][Full Text] [Related]
34. Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas: A Nonrandomized Phase 1/2 Clinical Trial.
Martin-Broto J; Hindi N; Lopez-Pousa A; Peinado-Serrano J; Alvarez R; Alvarez-Gonzalez A; Italiano A; Sargos P; Cruz-Jurado J; Isern-Verdum J; Dolado MC; Rincon-Pérez I; Sanchez-Bustos P; Gutierrez A; Romagosa C; Morosi C; Grignani G; Gatti M; Luna P; Alastuey I; Redondo A; Belinchon B; Martinez-Serra J; Sunyach MP; Coindre JM; Dei Tos AP; Romero J; Gronchi A; Blay JY; Moura DS
JAMA Oncol; 2020 Apr; 6(4):535-541. PubMed ID: 32077895
[TBL] [Abstract][Full Text] [Related]
35. Retroperitoneal soft tissue sarcoma: low-dose neoadjuvant radiation therapy followed by surgery with or without intraoperative radiotherapy and adjuvant radiation therapy.
Kirste S; Landenberger N; Scholber J; Henne K; Wittel UA; Grosu AL
Strahlenther Onkol; 2019 Jun; 195(6):558-565. PubMed ID: 30972454
[TBL] [Abstract][Full Text] [Related]
36. Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial.
Filleron T; Le Guellec S; Chevreau C; Cabarrou B; Lesluyes T; Lodin S; Massoubre A; Mounier M; Poublanc M; Chibon F; Valentin T
BMC Cancer; 2020 Jul; 20(1):716. PubMed ID: 32736540
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experience.
Peeken JC; Knie C; Kessel KA; Habermehl D; Kampfer S; Dapper H; Devecka M; von Eisenhart-Rothe R; Specht K; Weichert W; Wörtler K; Knebel C; Wilkens JJ; Combs SE
Radiat Oncol; 2019 Jan; 14(1):2. PubMed ID: 30626408
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the Role of Interdigitated Neoadjuvant Chemotherapy and Radiation in the Management of High-Grade Soft-Tissue Sarcoma: The Johns Hopkins Experience.
Raval RR; Frassica D; Thornton K; Meyer C; Ettinger DS; Frassica F; Weber K; Terezakis SA
Am J Clin Oncol; 2017 Apr; 40(2):214-217. PubMed ID: 25268069
[TBL] [Abstract][Full Text] [Related]
39. Tumor grading of soft tissue sarcomas using MRI-based radiomics.
Peeken JC; Spraker MB; Knebel C; Dapper H; Pfeiffer D; Devecka M; Thamer A; Shouman MA; Ott A; von Eisenhart-Rothe R; Nüsslin F; Mayr NA; Nyflot MJ; Combs SE
EBioMedicine; 2019 Oct; 48():332-340. PubMed ID: 31522983
[TBL] [Abstract][Full Text] [Related]
40. Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management.
Ahmed KA; Liveringhouse CL; Mills MN; Figura NB; Grass GD; Washington IR; Harris EE; Czerniecki BJ; Blumencranz PW; Eschrich SA; Scott JG; Diaz R; Torres-Roca JF
EBioMedicine; 2019 Sep; 47():163-169. PubMed ID: 31416721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
